Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01); Correction

Streszczenie

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of August 6, 2010 (75 FR 47602). The document announced the availability of grant funds for the support of FDA's Office of Orphan Products Development (OPD) grant program. The document was published with an error. This document corrects that error.